tc-510
·Code: TC-510
tc-510: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| TCR2 THERAPEUTICS INC. (TCRR) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
Frequently asked questions
Who is developing tc-510?
tc-510 is being developed by TCR2 THERAPEUTICS INC..
How many clinical trials involve tc-510?
BioSniper tracks 1 clinical trial involving tc-510.
Get deeper analysis on tc-510
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis